UPA LABS TIRZEPATIDE COMPOUND PEPTIDE 30MG VIAL ( Selfmix )

UPA TIRZEPATIDE 30MG VIALUPA Tirzepatide works by activating GIP and GLP-1 receptors, leading to increased insulin secretion, decreased glucagon release, slowed gastric emptying, and reduced food intake. Clinical trials have demonstrated its efficacy in improving glycemic control, fasting plasma glucose levels and body weight. Tirzepatide weight loss treatment is injected once a week to help you lose weight as part of a wider diet and exercise programme. Tirzepatide works by reducing your appetite and slowing down the movement of food from the stomach to the small intestine. This process helps to leave you feeling fuller for longer, making it easier to reduce your calorie intake. For this reason, tirzepatide has been released as a medication for weight loss.Dosing Range 2.5mg–7.5mg weekly
Injection Type Subcutaneous (once weekly)
Storage: Refrigerate at 2–8°C. 
Inject once a week – same day and time each week
Do not shake or freeze. Use only if solution is clear.Tirzepatide works best when increased gradually to reduce nausea and digestive upset.